Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Natsumi Tomita"'
Autor:
Hajime Nakamura, Rie Morita, Ryo Ito, Akira Sakurada, Natsumi Tomita, Yuya Hirata, Yusuke Kanari, Yuya Komatsu, Kunihiro Takanashi, Tomonori Anbo, Shinichi Katsuki
Publikováno v:
DEN Open, Vol 4, Iss 1, Pp n/a-n/a (2024)
Abstract Objectives The usefulness of 0.6% sodium alginate (SA) as a submucosal (SM) injection solution for endoscopic SM dissection (ESD) has gained attention over the past few years. However, using ESD for colorectal neoplastic lesions is not expli
Externí odkaz:
https://doaj.org/article/a020ef1448344340b285d0e621dfdcfd
Autor:
Natsumi Tomita, Yuji Hotta, Aya Naiki-Ito, Akimasa Sanagawa, Tomoya Kataoka, Yoko Furukawa-Hibi, Satoru Takahashi, Kazunori Kimura
Publikováno v:
Journal of Pharmacological Sciences, Vol 149, Iss 2, Pp 53-59 (2022)
Podocyte injury is responsible for nephrotic syndrome. Previously, we found that tadalafil, a phosphodiesterase 5 inhibitor, might have protective effects on podocytes. Here, we investigated the effects of tadalafil in a nephrotic syndrome model and
Externí odkaz:
https://doaj.org/article/65a43124c9864446886547e97751a934
Autor:
Yuko Yamamoto, Yuji Hotta, Natsumi Tomita, Aya Naiki-Ito, Ayae Kitagawa, Urara Kuboshiki, Tamaki Hagita, Misuzu Noda, Akimasa Sanagawa, Tomoya Kataoka, Masahiro Kondo, Yoko Furukawa-Hibi, Satoru Takahashi, Kazunori Kimura
Publikováno v:
Biochemistry and Biophysics Reports, Vol 33, Iss , Pp 101422- (2023)
Cisplatin (CDDP) is a widely used anticancer drug, but acute kidney injury (AKI) is one of the most important dose-limiting factors. Trace metal elements are present in various concentrations in the body and play an important role in maintaining norm
Externí odkaz:
https://doaj.org/article/56fd3104a4b1471fb42f3697499de767
Autor:
Natsumi Tomita, Yuji Hotta, Hidekazu Ito, Aya Naiki-Ito, Karin Matsuta, Yuko Yamamoto, Kazuki Ohashi, Tomoaki Hayakawa, Akimasa Sanagawa, Yasuhiro Horita, Masahiro Kondo, Tomoya Kataoka, Satoru Takahashi, Kazuya Sobue, Kazunori Kimura
Publikováno v:
Clinical and Experimental Nephrology. 27:382-391
Autor:
Natsumi Tomita, Yuji Hotta, Aya Naiki‐Ito, Kana Hirano, Tomoya Kataoka, Yasuhiro Maeda, Satoru Takahashi, Kazunori Kimura
Publikováno v:
Physiological Reports, Vol 8, Iss 17, Pp n/a-n/a (2020)
Abstract Phosphodiesterase 5 inhibitors are widely used to treat erectile dysfunction and lower urinary tract symptoms with benign prostatic hyperplasia. Recent studies have indicated the renoprotective effects of this class of compounds. Whether ren
Externí odkaz:
https://doaj.org/article/842b63e4ab604e07baf0b530aef86cb8
Autor:
TAKANOBU ASAKURA, TAKASHI HASHIMOTO, TAKAO ANDO, NATSUMI TOMITA, TOSHIHARU MATSUMOTO, ATSUSHI ARAKAWA, MASAHIKO TSURUMARU, YOSHIAKI KAJIYAMA
Publikováno v:
Juntendo Medical Journal. 68:363-368
Autor:
Naoya Ieda, Yuka Yoshikawa, Natsumi Tomita, Kei Ohkubo, Yuji Hotta, Mitsuyasu Kawaguchi, Kazunori Kimura, Hidehiko Nakagawa
Publikováno v:
Chemical Communications. 58:8420-8423
We found that N-nitrosoaminoanisole derivatives tethered to dyes work as photocontrollable nitrosonium cation releasers and are converted to potent nitric oxide releasers in the presence of sodium ascorbate.
Autor:
Kiichi Sugimoto, Shingo Kawano, Yutaka Kojima, Shun Ishiyama, Michitoshi Goto, Harumi Saeki, Masaya Kawai, Natsumi Tomita, Shuichiro Shiina, Makoto Takahashi, Shinya Munakata, Kazuhiro Sakamoto
Publikováno v:
International Cancer Conference Journal
We report our experience of an extremely rare case of a simultaneous extrahepatic metastasis of hepatocellular carcinoma (HCC) with long-term relapse-free survival, treated by laparoscopic resection of an abdominal wall tumor and subsequent radiofreq
Publikováno v:
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 46:735-739
Autor:
Tomoya Kataoka, Akimasa Sanagawa, Kazunori Kimura, Nanaka Mori, Natsumi Tomita, Yuji Hotta, Masahiro Tohkin
Publikováno v:
Anti-cancer drugs. 32(10)
Acute kidney injury (AKI) associated with cancer chemotherapy can be life-threatening. Inhibitors of rapidly accelerated fibrosarcoma kinase B (BRAF)-mutants and mitogen-activated extracellular signal-regulated kinase (MEK) administered as combinatio